Ruminant BioTech Overview
- Year Founded
-
2021

- Status
-
Private
- Latest Deal Type
-
Series A
- Investors
-
9
Ruminant BioTech General Information
Description
Developer of slow-release device designed for long-term controlled-release methane mitigation. The company's device contains a naturally occurring organic compound to deliver high levels of methane knockdown over that time period, enabling farmers to reduce greenhouse gas emissions.
Contact Information
Website
www.ruminantbiotech.comCorporate Office
- 105 Bellevue Road
- Road 4
- Hamilton, Waikato 3284
- New Zealand
Corporate Office
- 105 Bellevue Road
- Road 4
- Hamilton, Waikato 3284
- New Zealand
Ruminant BioTech Timeline
Ruminant BioTech Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Early Stage VC (Series A) | 07-Feb-2025 | Completed | Product Development | |||
3. Secondary Transaction - Private | Completed | Product Development | ||||
2. Early Stage VC | 06-Apr-2023 | $7.58M | $7.58M | Completed | Product Development | |
1. Grant | 30-Nov-2022 | $7.8M | Completed | Product Development |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Ruminant BioTech Patents
Ruminant BioTech Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2024903288-A0 | Gastric residence device | Pending | 11-Oct-2024 | ||
US-20240139103-A1 | Devices and methods for delivering methane inhibiting compounds to animals | Active | 02-Nov-2022 | ||
US-12115248-B2 | Devices and methods for delivering methane inhibiting compounds to animals | Active | 02-Nov-2022 | ||
US-20240398702-A1 | Devices and methods for delivering methane inhibiting compounds to animals | Pending | 02-Nov-2022 | ||
AU-2021900932-A0 | Improvement to methods and devices for animal production | Inactive | 30-Mar-2021 |
Ruminant BioTech Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Agmardt | Not-For-Profit Venture Capital | Minority | ||
AgriZeroNZ | Impact Investing | Minority | ||
Akina (NZ) | Impact Investing | Minority | ||
Centre for Climate Action Joint Venture | Corporation | Minority | ||
Craigmore Sustainables | Real Estate | Minority |
Ruminant BioTech FAQs
-
When was Ruminant BioTech founded?
Ruminant BioTech was founded in 2021.
-
Where is Ruminant BioTech headquartered?
Ruminant BioTech is headquartered in Hamilton, New Zealand.
-
What industry is Ruminant BioTech in?
Ruminant BioTech’s primary industry is Biotechnology.
-
Is Ruminant BioTech a private or public company?
Ruminant BioTech is a Private company.
-
What is Ruminant BioTech’s current revenue?
The current revenue for Ruminant BioTech is
. -
How much funding has Ruminant BioTech raised over time?
Ruminant BioTech has raised $7.58M.
-
Who are Ruminant BioTech’s investors?
Agmardt, AgriZeroNZ, Akina (NZ), Centre for Climate Action Joint Venture, and Craigmore Sustainables are 5 of 9 investors who have invested in Ruminant BioTech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »